SKI Market

A+| A| A-|

Indian Indices

Sensex

77,094.07 291.17
( 0.38%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

72,454.13 1,204.07
(1.69%)

Nikkei 225

10,441.93 78.66
(0.76%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

391.1437121

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

35.83

86995.37

EPS(TTM)

Face Value()

Div & Yield %

41.81

0.27

Back

Board of Alkem Laboratories recommends final dividend

May 28,2026

Alkem Laboratories announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 10 per equity Share (i.e. 500%) , subject to the approval of the shareholders.

77,094.07 291.17 ( 0.38%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

72,454.13 1,204.07 (1.69%)

10,441.93 78.66 (0.76%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)